Molecular Therapy

Elsevier BV, United States

POSI-J-023625eISSN 1525-0016IndexedPartially verifiedCurrent

Journal website Publications OpenAlex Indexing certificate Record JSON

Indicators

Lifecycle rating

AJR-E-1.0

Not Yet Rateable

Method

Citation score (PCS)

PCS-1.0

20.23

2022 to 2025, 1,587 items

Adequate sample

Method

Citation impact (PCI)

PCI-1.0

7.83

2023 to 2024, 708 citable items

Adequate sample

Method

PQF (automated)

n/a

Not assessed

Method

Ranked 50/401 in Biological Sciences (PCS-Q1, percentile 87.7), and 326/4067 overall, by PCS.PCS determines the PCS-Q ranking only; it does not determine Citation Rank, Citation Percentile or Citation Quartile.

Identity

POSI IDposi-data registry/: POSI-J-023625Identifier
eISSNISSN Portal / Crossref: 1525-0016Identifier
pISSNISSN Portal / Crossref: Not recordedIdentifier
OpenAlex sourceOpenAlex: S51596929Identifier
TitleCrossref / OpenAlex: Molecular TherapyRegistry
PublisherCrossref / OpenAlex: Elsevier BVRegistry
ISSN countryISSN Portal: Not recordedRegistry

Declared by the publisher

Stated by the journal about itself. POSI records these as declared and does not present them as measured.

Declared countryPublisher: United StatesDeclared
LanguagePublisher / DOAJ: EnglishDeclared
FrequencyPublisher: Not recordedDeclared
LicensePublisher / DOAJ: Not recordedDeclared
Peer reviewPublisher: Not recordedDeclared
WebsitePublisher: https://www.sciencedirect.com/science/journal/15250016Declared

Registry and computed values

ArticlesCrossref: 22,910Registry
Open accessDOAJ / OpenAlex: NoRegistry
DOAJ statusDOAJ: Not recordedRegistry
PSC subjectOpenAlex topics → PSC crosswalk: P1.06 Biological SciencesComputed
PSC confidenceposi-engine: highComputed